| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ADC Therapeutics SA | Director | Common Shares | 144,043 | $515,673 | $3.58 | 13 Jun 2025 | Direct |
| DBV Technologies S.A. | Director | Warrant (right to buy) | 5,000 | 10 Jun 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ADCT | ADC Therapeutics SA | 13 Jun 2025 | 1 | -$9,251 | 4 | Director | 17 Jun 2025, 17:02 |
| ADCT | ADC Therapeutics SA | 03 Jun 2025 | 1 | $0 | 4 | Director | 05 Jun 2025, 17:07 |
| ADCT | ADC Therapeutics SA | 17 Jun 2024 | 1 | -$4,153 | 4 | Director | 18 Jun 2024, 21:40 |
| ADCT | ADC Therapeutics SA | 13 Jun 2024 | 1 | $0 | 4 | Director | 14 Jun 2024, 17:23 |
| ADCT | ADC Therapeutics SA | 02 Jan 2024 | 0 | $0 | 3 | Director | 02 Jan 2024, 20:10 |
| DBVT | DBV Technologies S.A. | 10 Jun 2021 | 1 | +$35,600 | 4 | Director | 11 Jun 2021, 16:52 |